cyclosporine has been researched along with Hypersensitivity in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 15 (65.22) | 18.2507 |
| 2000's | 3 (13.04) | 29.6817 |
| 2010's | 5 (21.74) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Achterrath, U; Duflos, M; Emig, P; Fouchard, F; Günther, E; Kutscher, B; Le Baut, G; Menciu, C; Nickel, B; Schmidt, J; Szelenyi, I | 1 |
| Diaz, S; Gilbert, S; Koch, SN; Rendahl, A; Torres, SMF | 1 |
| Cannon, A; Fontaine, J; Forsythe, P; King, S; Prélaud, P; Roberts, E; Seewald, W; Steffan, J | 1 |
| Celani, C; Duse, M; Grenga, R; Lollobrigida, V; Nebbioso, M; Zicari, AM | 1 |
| Dehlink, E; Eiwegger, T; Graf, A; Gruber, S; Kikic, Z; Konstantin, H; Mayer, E; Szépfalusi, Z; Tiringer, K | 1 |
| Hong, JH; Kim, SH; Lee, YC | 1 |
| Agis, H; Bankl, HC; Kraft, D; Lechner, K; Scheiner, O; Sillaber, C; Sperr, WR; Valent, P; Valenta, R | 1 |
| Fukata, Y; Okudaira, H; Suehiro, S; Yago, H; Yamamoto, K; Yanagihara, Y; Yoshii, H | 1 |
| Inagaki, N; Nagai, H; Tanaka, H; Yamaguchi, S | 1 |
| Bonham, CA; Thomson, AW | 1 |
| Andius, P; Arakawa, H; Kawikova, I; Löfdahl, CG; Lötvall, J; Skoogh, BE | 1 |
| Renz, H | 1 |
| Borghesan, F; Faggian, D; Leonardi, A; Plebani, M; Secchi, A | 1 |
| Ezeamuzie, CI | 1 |
| Hannouche, D; Hoang-Xuan, T; Prisant, O; Robin, H | 1 |
| Ponvert, C; Scheinmann, P | 1 |
| Ikezawa, K; Kaminuma, O; Kikkawa, H; Mori, A; Naito, K; Nakata, A; Ogawa, K; Okudaira, H; Suko, M | 1 |
| Egan, RW; Falcone, A; Garlisi, CG; Hegde, V; Jakway, JP; Kung, TT; Motasim Billah, M; Patel, M; Razac, S; Shah, H; Shortall, J; Stelts, D; Umland, SP | 1 |
| Baumann, LS; Kerdel, F | 1 |
| Essayan, DM; Huang, SK; Oriente, A; Pacocha, SE | 1 |
| Cadot, P; Ceuppens, JL; Diaz, JF; Engelborghs, Y; Proost, P; Stevens, EA; Van Damme, J | 1 |
| Dinges, MM; Schlievert, PM | 1 |
| Inoue, M; Kawa, K; Nakayama, M; Okamura, T; Takeuchi, M; Yagi, K | 1 |
3 review(s) available for cyclosporine and Hypersensitivity
| Article | Year |
|---|---|
[Effector cells in allergy: biological principles and new pharmacologic concepts].
Topics: Allergens; Basophils; Cyclosporine; Desensitization, Immunologic; Eosinophils; Humans; Hypersensitivity; Immunoglobulin E; Mast Cells; Tacrolimus | 1993 |
Anti-inflammatory agents in allergic diseases.
Topics: Anti-Inflammatory Agents; Cyclosporine; Humans; Hypersensitivity; Inflammation | 1995 |
[New experimental therapies for type I allergy].
Topics: Animals; Cyclosporine; Humans; Hypersensitivity; Immunoglobulin E; Immunoglobulins, Intravenous; Interferon-gamma; Methotrexate; Peptides; Receptors, Interleukin; Receptors, Interleukin-4; T-Lymphocyte Subsets | 1994 |
4 trial(s) available for cyclosporine and Hypersensitivity
| Article | Year |
|---|---|
Subcutaneous administration of ciclosporin in 11 allergic cats - a pilot open-label uncontrolled clinical trial.
Topics: Animals; Cat Diseases; Cats; Cyclosporine; Dermatitis, Atopic; Female; Hypersensitivity; Male; Pilot Projects; Prospective Studies; Pruritus; Skin Diseases; Subcutaneous Absorption | 2018 |
Dose tapering for ciclosporin in cats with nonflea-induced hypersensitivity dermatitis.
Topics: Animals; Cat Diseases; Cats; Cyclosporine; Dermatitis; Drug Administration Schedule; Hypersensitivity | 2013 |
Allergic sensitization in kidney-transplanted patients prevails under tacrolimus treatment.
Topics: Adolescent; Adult; Cross-Sectional Studies; Cyclosporine; Eosinophilia; Humans; Hypersensitivity; Immunoglobulin E; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Multivariate Analysis; Sensitivity and Specificity; Skin Tests; Tacrolimus; Young Adult | 2011 |
Systemic cyclosporine A in severe atopic keratoconjunctivitis.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Conjunctivitis, Allergic; Cyclosporine; Dermatitis, Atopic; Female; Humans; Hypersensitivity; Immunosuppressive Agents; Keratitis; Kidney; Male; Middle Aged; Prednisone; Time Factors; Treatment Outcome | 1997 |
16 other study(ies) available for cyclosporine and Hypersensitivity
| Article | Year |
|---|---|
New N-(pyridin-4-yl)-(indol-3-yl)acetamides and propanamides as antiallergic agents.
Topics: Acetylcholine; Animals; Anti-Allergic Agents; Bronchoalveolar Lavage; Capillary Permeability; Carbachol; Eosinophilia; Guinea Pigs; Histamine Release; Hypersensitivity; In Vitro Techniques; Indoleacetic Acids; Interleukin-4; Interleukin-5; Male; Mast Cells; Muscle Contraction; Muscle, Smooth; Peritoneal Cavity; Polyunsaturated Alkamides; Pyridines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Rhinitis, Allergic, Perennial; Structure-Activity Relationship; Trachea | 1999 |
Pathogenesis of Vernal Keratoconjunctivitis and Associated Factors.
Topics: Adolescent; Adult; Allergens; Autoimmunity; Child; Child, Preschool; Conjunctivitis, Allergic; Cyclosporine; Female; Humans; Hypersensitivity; Immunoglobulin E; Immunosuppressive Agents; Male; Microscopy, Confocal; Ophthalmic Solutions; Risk Factors; Skin Tests; Visual Acuity | 2015 |
Ursolic acid, a potential PPARγ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma.
Topics: Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Cell Count; Cell Line; Cyclosporine; Disease Models, Animal; Down-Regulation; Eosinophils; Female; GATA3 Transcription Factor; Hypersensitivity; Immunoglobulin E; Inflammation; Interleukin-13; Interleukin-17; Interleukin-5; Interleukins; Lung; Macrophages; Mice; Mice, Inbred BALB C; Ovalbumin; PPAR gamma; RNA, Messenger; STAT6 Transcription Factor; Th2 Cells; Triterpenes; Ursolic Acid | 2013 |
[Inhibitory effect of histamine-added mouse gamma-globulin on eosinophil accumulation induced by allergen in BALB/c mice].
Topics: Allergens; Animals; Chronic Disease; Cyclosporine; Drug Combinations; Eosinophils; Female; gamma-Globulins; Histamine; Hypersensitivity; Mice; Mice, Inbred BALB C; Peritoneal Cavity | 1995 |
Effect of some immunosuppressors on allergic bronchial inflammation and airway hyperresponsiveness in mice.
Topics: Aerosols; Animals; Bronchial Provocation Tests; Chemotaxis, Leukocyte; Cyclophosphamide; Cyclosporine; Hypersensitivity; Immunosuppressive Agents; Interleukin-5; Mice; Mice, Inbred BALB C; Mice, Nude; Ovalbumin; Respiratory System; Ribonucleosides; Tacrolimus | 1995 |
Treatment with cyclosporin A during sensitization with trimellitic anhydride attenuates the airway responses to allergen challenge three weeks later.
Topics: Administration, Oral; Airway Resistance; Allergens; Animals; Betamethasone; Bronchial Hyperreactivity; Cyclosporine; Enzyme-Linked Immunosorbent Assay; Guinea Pigs; Histamine H1 Antagonists; Hypersensitivity; Immunoglobulin G; Male; Phthalazines; Phthalic Anhydrides; Serum Albumin; Specific Pathogen-Free Organisms | 1994 |
Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis.
Topics: Adolescent; Blood Proteins; Cell Count; Child; Cyclosporine; Dexamethasone; Eosinophil Granule Proteins; Eosinophils; Female; Humans; Hypersensitivity; Inflammation Mediators; Keratoconjunctivitis; Male; Reference Values; Ribonucleases; Seasons; Tears | 1995 |
Anti-allergic activity of cyclosporin-A metabolites and their interaction with the parent compound and FK 506.
Topics: Animals; Anti-Allergic Agents; beta-N-Acetylhexosaminidases; Cyclosporine; Cyclosporins; Hypersensitivity; Immunoglobulin E; Leukemia, Mast-Cell; Rats; Tacrolimus; Tumor Cells, Cultured | 1996 |
Hyposensitization is contraindicated in Hymenoptera venom-allergic children treated with cyclosporin.
Topics: Bee Venoms; Child; Contraindications; Cyclosporine; Humans; Hypersensitivity; Immunosuppressive Agents; Immunotherapy; Kidney Transplantation | 1998 |
Evidence that cyclosporin A and dexamethasone inhibit allergic airway eosinophilic inflammation via suppression of interleukin-5 synthesis by T cells.
Topics: Animals; Bronchial Hyperreactivity; CD4-Positive T-Lymphocytes; Cyclosporine; Dexamethasone; Eosinophilia; Hypersensitivity; Interleukin-2; Interleukin-4; Interleukin-5; Male; Mice; Mice, Inbred BALB C | 1998 |
Effects of cyclosporin A and dinactin on T-cell proliferation, interleukin-5 production, and murine pulmonary inflammation.
Topics: Animals; Anti-Bacterial Agents; CD28 Antigens; CD3 Complex; CD4-Positive T-Lymphocytes; Cyclosporine; Cytokines; Dose-Response Relationship, Drug; Humans; Hypersensitivity; Interleukin-5; Lymphocyte Activation; Macrolides; Mice; Respiratory Hypersensitivity; RNA, Messenger | 1999 |
The treatment of bovine collagen allergy with cyclosporin.
Topics: Administration, Oral; Adult; Animals; Cattle; Collagen; Cyclosporine; Female; Humans; Hypersensitivity; Immunosuppressive Agents; Surgery, Plastic | 1999 |
Regulation of antigen-induced human T-lymphocyte responses by calcineurin antagonists.
Topics: Calcineurin Inhibitors; Cyclosporine; Dose-Response Relationship, Drug; Gene Expression Regulation; Humans; Hypersensitivity; Interferon-gamma; Interleukins; Lymphocyte Activation; Signal Transduction; T-Lymphocytes, Helper-Inducer; Tacrolimus | 1999 |
Purification and characterization of an 18-kd allergen of birch (Betula verrucosa) pollen: identification as a cyclophilin.
Topics: Allergens; Amino Acid Sequence; Antigens, Plant; Cyclosporine; Humans; Hypersensitivity; Immunoblotting; Immunoglobulin E; Immunophilins; Molecular Sequence Data; Molecular Weight; Peptidylprolyl Isomerase; Plant Proteins; Pollen; Skin Tests; Trees | 2000 |
Role of T cells and gamma interferon during induction of hypersensitivity to lipopolysaccharide by toxic shock syndrome toxin 1 in mice.
Topics: Adoptive Transfer; Animals; Antibodies, Monoclonal; Bacterial Toxins; Cyclosporine; Enterotoxins; Female; Hypersensitivity; Interferon-gamma; Lipopolysaccharides; Lymphocyte Transfusion; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, SCID; Superantigens; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2001 |
Mosquito allergy and Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Culicidae; Cyclosporine; Epstein-Barr Virus Infections; Female; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Humans; Hypersensitivity; Immunocompromised Host; Immunosuppressive Agents; Insect Bites and Stings; Killer Cells, Natural; Lymphoproliferative Disorders; Male; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Antigen, T-Cell, gamma-delta; Remission Induction; Skin; T-Lymphocyte Subsets; Virus Activation | 2001 |